Ankylosing Spondylitis Research Today is a free monthly online journal that collates and summarizes the latest research about Ankylosing Spondylitis, including details on diagnosis, treatment, symptoms, causes.

Volume 2 (2005), Issue 4 (April)

1. Extraintestinal manifestations of Crohn's disease.
   Digestion, 71(1): 31-6. [Abstract] [Full-text]
2. The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity.
   Clin Rheumatol, 24(2): 123-8. [Abstract] [Full-text]
3. Delayed response to anti-tuberculosis treatment in a patient on infliximab.
   Respir Med, 99(5): 648-52. [Abstract] [Full-text]
4. Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab.
   Arthritis Rheum, 52(4): 1224-6. [Abstract] [Full-text]
5. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
   Arthritis Rheum, 52(4): 1205-15. [Abstract] [Full-text]
6. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept.
   Arthritis Rheum, 52(4): 1216-23. [Abstract] [Full-text]
7. Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis.
   Ann Rheum Dis, 64(5): 722-9. [Abstract] [Full-text]
8. Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care.
   Ann Rheum Dis, 64(5): 659-63. [Abstract] [Full-text]
9. Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging.
   Ann Rheum Dis, 64(5): 730-4. [Abstract] [Full-text]
10. Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis.
    Ann Rheum Dis, 64(5): 765-6. [Abstract] [Full-text]
11. Validity and reliability of an Italian version of the revised Leeds disability questionnaire for patients with ankylosing spondylitis.
    Rheumatology (Oxford), 44(5): 666-9. [Abstract] [Full-text]
12. Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years.
    Rheumatology (Oxford), 44(5): 670-6. [Abstract] [Full-text]
13. Patient-assessed health in ankylosing spondylitis: a structured review.
    Rheumatology (Oxford), 44(5): 577-86. [Abstract] [Full-text]
14. Sulfasalazine for ankylosing spondylitis.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
15. Diverse effects of infliximab and etanercept on T lymphocytes.
    Semin Arthritis Rheum, 34(5): 23-7. [Abstract] [Full-text]
16. Aseptic discitis in patients with ankylosing spondylitis: a retrospective study of 14 cases.
    Joint Bone Spine, 72(3): 248-53. [Abstract] [Full-text]

© 2004-2008 Ankylosing Spondylitis Research Today. All Rights Reserved.